Adaptive Trial Scheduling in Naming Treatment for Aphasia

Launched by UNIVERSITY OF PITTSBURGH · Dec 7, 2022

Keywords

ClinConnect Summary

This clinical trial is studying new ways to help people with aphasia, a language disorder often caused by a stroke. Aphasia can make it hard for individuals to find the right words, which can be very frustrating. The focus of this study is on developing treatments that not only help improve naming skills but also help people use these skills in their everyday lives, even after the treatment has ended. Researchers are particularly interested in how different scheduling of therapy sessions can affect the benefits participants receive.

To be eligible for this trial, participants need to have a diagnosis of chronic aphasia for more than six months after a stroke affecting the left side of the brain. They should also show specific language difficulties on a test called the Comprehensive Aphasia Test. Participants must have a reliable internet connection and be comfortable with telehealth sessions. Those with other serious neurological conditions, significant difficulties understanding spoken language, or certain mental health issues may not be able to take part. If you join the study, you can expect to engage in treatment sessions that are designed to help improve your language skills and learn how to apply them in daily activities.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Existing diagnosis of chronic (\>6 months) aphasia subsequent to left hemisphere stroke.
• • Impaired performance on 2/8 sections of the Comprehensive Aphasia Test.
• • Must have access to a high-speed internet connection and be able to participate in telehealth.
• Exclusion Criteria:
• • History of other acquired or progressive neurological disease.
• • Significant language comprehension impairments (per performance on the CAT - individuals will be excluded if their spoken language comprehension mean modality T- score on the CAT falls below 40).
• • Unmanaged drug / alcohol dependence.
• • Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.

Trial Officials